These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 38146639)
1. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease. Samanta S; Akhter F; Roy A; Chen D; Turner B; Wang Y; Clemente N; Wang C; Swerdlow RH; Battaile KP; Lovell S; Yan SF; Yan SS Brain; 2024 May; 147(5):1710-1725. PubMed ID: 38146639 [TBL] [Abstract][Full Text] [Related]
2. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Du H; Guo L; Fang F; Chen D; Sosunov AA; McKhann GM; Yan Y; Wang C; Zhang H; Molkentin JD; Gunn-Moore FJ; Vonsattel JP; Arancio O; Chen JX; Yan SD Nat Med; 2008 Oct; 14(10):1097-105. PubMed ID: 18806802 [TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury. Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123 [TBL] [Abstract][Full Text] [Related]
4. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Du H; Guo L; Zhang W; Rydzewska M; Yan S Neurobiol Aging; 2011 Mar; 32(3):398-406. PubMed ID: 19362755 [TBL] [Abstract][Full Text] [Related]
5. Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors. Valasani KR; Vangavaragu JR; Day VW; Yan SS J Chem Inf Model; 2014 Mar; 54(3):902-12. PubMed ID: 24555519 [TBL] [Abstract][Full Text] [Related]
6. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction. Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661 [TBL] [Abstract][Full Text] [Related]
7. Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration. Du H; Guo L; Wu X; Sosunov AA; McKhann GM; Chen JX; Yan SS Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2517-27. PubMed ID: 23507145 [TBL] [Abstract][Full Text] [Related]
8. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons. Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999 [TBL] [Abstract][Full Text] [Related]
9. Genetic Approach to Elucidate the Role of Cyclophilin D in Traumatic Brain Injury Pathology. Readnower RD; Hubbard WB; Kalimon OJ; Geddes JW; Sullivan PG Cells; 2021 Jan; 10(2):. PubMed ID: 33498273 [TBL] [Abstract][Full Text] [Related]
10. Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release. Guo HX; Wang F; Yu KQ; Chen J; Bai DL; Chen KX; Shen X; Jiang HL Acta Pharmacol Sin; 2005 Oct; 26(10):1201-11. PubMed ID: 16174436 [TBL] [Abstract][Full Text] [Related]
11. F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline. Yan S; Du F; Wu L; Zhang Z; Zhong C; Yu Q; Wang Y; Lue LF; Walker DG; Douglas JT; Yan SS Diabetes; 2016 Nov; 65(11):3482-3494. PubMed ID: 27554467 [TBL] [Abstract][Full Text] [Related]
12. Caspase-3 cleaved tau impairs mitochondrial function through the opening of the mitochondrial permeability transition pore. Pérez MJ; Ibarra-García-Padilla R; Tang M; Porter GA; Johnson GVW; Quintanilla RA Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166898. PubMed ID: 37774936 [TBL] [Abstract][Full Text] [Related]
13. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. Nguyen TT; Stevens MV; Kohr M; Steenbergen C; Sack MN; Murphy E J Biol Chem; 2011 Nov; 286(46):40184-92. PubMed ID: 21930693 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Rao VK; Carlson EA; Yan SS Biochim Biophys Acta; 2014 Aug; 1842(8):1267-72. PubMed ID: 24055979 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta. Du H; Yan SS Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093 [TBL] [Abstract][Full Text] [Related]
16. Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease. Gauba E; Chen H; Guo L; Du H Neurobiol Dis; 2019 Jan; 121():138-147. PubMed ID: 30266287 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction. Valasani KR; Sun Q; Fang D; Zhang Z; Yu Q; Guo Y; Li J; Roy A; ShiDu Yan S ACS Med Chem Lett; 2016 Mar; 7(3):294-9. PubMed ID: 26985318 [TBL] [Abstract][Full Text] [Related]
19. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. Xie Y; Tan Y; Zheng Y; Du X; Liu Q J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066 [TBL] [Abstract][Full Text] [Related]
20. Nano-Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits. Zhang Q; Song Q; Yu R; Wang A; Jiang G; Huang Y; Chen J; Xu J; Wang D; Chen H; Gao X Adv Sci (Weinh); 2023 Mar; 10(7):e2204596. PubMed ID: 36703613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]